.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Fish and Richardson
Julphar
Boehringer Ingelheim
Merck
Covington
US Army
Baxter
Novartis
Healthtrust

Generated: November 21, 2017

DrugPatentWatch Database Preview

Liotrix (t4;t3) - Generic Drug Details

« Back to Dashboard

What are the generic sources for liotrix (t4;t3) and what is the scope of liotrix (t4;t3) patent protection?

Liotrix (t4;t3)
is the generic ingredient in ten branded drugs marketed by Forest Labs and Parke Davis, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for liotrix (t4;t3)

US Patents:0
Tradenames:10
Applicants:2
NDAs:2
Suppliers / Packagers: 1
Drug Prices:see low prices
DailyMed Link:liotrix (t4;t3) at DailyMed

Pharmacology for liotrix (t4;t3)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis
EUTHROID-0.5
liotrix (t4;t3)
TABLET;ORAL016680-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Forest Labs
THYROLAR-0.25
liotrix (t4;t3)
TABLET;ORAL016807-001Approved Prior to Jan 1, 1982RXYesNo► Subscribe► Subscribe► Subscribe
Parke Davis
EUTHROID-1
liotrix (t4;t3)
TABLET;ORAL016680-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Forest Labs
THYROLAR-3
liotrix (t4;t3)
TABLET;ORAL016807-003Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Parke Davis
EUTHROID-3
liotrix (t4;t3)
TABLET;ORAL016680-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Forest Labs
THYROLAR-1
liotrix (t4;t3)
TABLET;ORAL016807-004Approved Prior to Jan 1, 1982RXYesNo► Subscribe► Subscribe► Subscribe
Forest Labs
THYROLAR-2
liotrix (t4;t3)
TABLET;ORAL016807-002Approved Prior to Jan 1, 1982RXYesNo► Subscribe► Subscribe► Subscribe
Forest Labs
THYROLAR-5
liotrix (t4;t3)
TABLET;ORAL016807-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Forest Labs
THYROLAR-0.5
liotrix (t4;t3)
TABLET;ORAL016807-005Approved Prior to Jan 1, 1982RXYesNo► Subscribe► Subscribe► Subscribe
Parke Davis
EUTHROID-2
liotrix (t4;t3)
TABLET;ORAL016680-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Teva
Fuji
Cipla
Accenture
Healthtrust
Federal Trade Commission
Cerilliant
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot